GRAND ITASCA CLINIC AND HOSPITAL — History
CCN 240064 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$118M
Latest Revenue (FY2022)
+10.2%
Revenue CAGR (3yr)
5.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $97M | $114M | $118M | +3.2% | +10.2% |
| Operating Expenses | $99M | $111M | $111M | +0.8% | +6.1% |
| Operating Margin | -2.1% | 3.0% | 5.3% | +75.2% | +0.0% |
| Net Income | $-2M | $3M | $6M | +80.8% | +0.0% |
| Licensed Beds | 36 | 36 | 34 | -5.6% | -2.8% |
| Total Patient Days | 5,700 | 6,516 | 6,705 | +2.9% | +8.5% |
| Medicare Day % | 40% | 39% | 37% | -3.6% | -3.6% |
| Medicaid Day % | 9% | 8% | 9% | +13.9% | +0.4% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +21.4% ($97M → $118M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.2%
This Hospital
+7.6%
State Avg
Latest Margin
5.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $128M | 9.0% |
| FY2024 (proj) | $138M | 12.8% |
| FY2025 (proj) | $149M | 16.5% |